JANAI GIBSON: Open Payments
NPI 1346419652 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 44 payments from 11 companies in 2025. Trend: 2023 $550 · 2024 $822 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $252 |
| Merck Sharp & Dohme LLC | 8 | $196 |
| Eisai Inc. | 7 | $158 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $92 |
| Daiichi Sankyo Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Ethicon US, LLC | 1 | $16 |
Products named: TIVDAK, KEYTRUDA, Lenvima, JOURNAVX, LYNPARZA, Enhertu, ELAHERE, JEMPERLI.
Industry payments across GA — which companies pay providers there.
